BridgeBio Pharma Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Priyanka Grover, [Malcolm Kuno and Chattle Smith] from the team. Our next presenting company is BridgeBio. Presenting on behalf of the company, we have CEO, Neil Kumar.
I want to remind attendees to us to Ask A Question feature in the portal. And if you put more a question in there, I'm happy to ask on your behalf. With that, Neil, take it away.
Thanks, Anupam, for that introduction, and thanks to the Phil and the entire JPM team for the opportunity to present today. I'll refer to slide numbers as I move through here for those of you following along at home with the presentation. Despite some meaningful progress against our pipeline and portfolio in the early stages of 2021, importantly, with our proof-of-concept data in ADH1 as well as our first 2
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
